Over the last few weeks, the European Medicines Agency (EMA) announced they have begun a “rolling review” process on COVID-19 vaccines from AstraZeneca in collaboration with Oxford University, Moderna and from Pfizer in partnership with BioNTech. The announcements are indicative …
Scepticism about adverse effects and actual lack of efficacy in immunisation practices can become an important negative factor when a vaccine against coronavirus becomes available, according to the head of the EU's medicines agency (EMA), Guido Rasi.
A strong EU regulatory framework on medical cannabis is needed to provide investors with stability but also to give peace of mind to patients struggling with fragmented legislation among member states, socialist MEP Miriam Dalli said.
The European Medicines Agency is looking to sublet its former headquarters in the financial district of London, after a British court ruled on Wednesday (20 February) that it cannot break its lease despite the UK’s withdrawal from the EU.
The European Medicines Agency (EMA) is to scale back operations further as it copes with higher than expected staff losses, triggered by the watchdog's forced relocation from London to Amsterdam because of Brexit.
The smooth transition of the EU drug agency from London to Amsterdam is threatened by delays in the Netherlands, whose bid to win the agency may have been misleading, a top representative of Italian pharmaceuticals told EURACTIV.com.
The preparations for relocating the European Medicines Agency to the Netherlands next year are underway and on schedule, a senior Dutch government official in the EU told EURACTIV.com on Wednesday (31 January), after recent media reports suggested that Italy wants to appeal to the EU Court.
Dutch officials and the head of the European Medicines Agency (EMA) sought yesterday (29 January) to allay any jitters among the agency's 900 London-based staff who are being asked to move to Amsterdam because of Britain's departure from the EU.
Public health organisations and EU lawmakers say the closed-door meetings before the submission of a new drug between the pharma industry and the European Medicines Agency (EMA), a key player in the continent’s healthcare industry, should be more transparent.
Pharmaceutical companies face a multi-million euro bill in regulatory costs regardless of whether the UK reaches a ‘soft’ or ‘hard’ Brexit deal with the European Union, industry leaders warned on Tuesday (19 December).
Amsterdam and Paris won the right to host the two EU agencies that must leave London on Brexit after a dramatic ministerial meeting in Brussels on Monday (20 November) that left both result decided by drawing lots after votes were tied.
In a visit to Rome yesterday (14 November) Bulgarian Prime Minister Boyko Borissov praised his host Paolo Gentiloni for stopping refugees from Libya, and lashed out at EU’s diplomacy, which is led by another Italian, Federica Mogherini.
EU ministers will vote by secret ballot on the relocation of two EU agencies currently based in London at the General Affairs Council on 20 November. The ballot papers will then be destroyed and no record kept.
Slovakia's prime minister, president and parliament speaker pledged yesterday (23 October) to keep to a pro-European path, a day after its Czech neighbours became the latest central European ex-Communists to elect a populist taking a hard line on the EU.
The European Medicines Agency approved 39 new cancer drugs between 2009 and 2013 despite having no evidence that they worked, unnecessarily exposing patients to toxicity, researchers said Thursday (5 October).
In assessing the relocation of the EU drugs agency EMA, old member states have a "moral and political obligation" to give an advantage to those candidate countries that do not currently host another EU agency, Croatia’s health minister told EURACTIV.com.